系统性红斑狼疮重性抑郁障碍的免疫代谢特征
本研究基于LUPIL-2研究99例患者的深部流式细胞术免疫表型、肠道菌群和靶向代谢组学数据,识别与SLE重性抑郁障碍相关的候选免疫代谢生物标志物,并在独立队列中验证。SLEMDD患者表现为初始CD4⁺T细胞和初始调节性T细胞减少、ICOS⁺效应记忆Treg增加,菌群多样性降低及代谢通路紊乱,整合分析区分SLEMDD与SLEnon-MDD的准确率可达85%。
要点
- SLEMDD患者初始CD4⁺T和初始Treg减少、ICOS⁺效应记忆Treg增加,分类准确率94%。
- SLEMDD患者肠道菌群多样性降低,Akkermansia muciniphila耗竭、Faecalibacterium prausnitzii富集。
- 代谢组学显示犬尿氨酸和短链脂肪酸通路紊乱,包括丁酸水平降低。
核心结论
- SLEMDD与Treg表型改变、肠道菌群组成变化和代谢通路紊乱相关的免疫代谢特征有关。
研究设计与样本
- 分析LUPIL-2研究(NCT02955615)99例患者的深部流式细胞术免疫表型、肠道菌群谱和靶向质谱代谢组学。
- 采用无监督主成分分析和有监督决策树分类识别生物学特征,并在TRANSIMMUNOM研究(NCT02466217)的独立队列中验证。
主要发现
- SLEMDD患者初始CD4⁺T细胞和初始调节性T细胞减少,ICOS⁺效应记忆Treg增加,分类准确率94%。
- SLEMDD患者肠道菌群多样性降低,Akkermansia muciniphila耗竭、Faecalibacterium prausnitzii富集。
- 代谢组学分析显示犬尿氨酸和短链脂肪酸通路紊乱,包括丁酸水平降低。
- 整合分析显示Treg活化、微生物代谢物和免疫通路协调改变,区分SLEMDD与SLEnon-MDD的准确率高达85%。
关键数值与推荐
- SLEMDD免疫特征分类准确率94%。
- 整合分析区分SLEMDD与SLEnon-MDD的准确率高达85%。
临床怎么用
- SLEMDD的免疫代谢特征为未来免疫调节或靶向菌群的治疗策略提供了依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Systemic lupus erythematosus (SLE) frequently affects the central nervous system, leading to neuropsychiatric SLE (NPSLE). Major depressive disorder in SLE (SLEMDD) is the most frequent manifestation of NPSLE and is believed to arise from an immune-mediated process. However, biomarkers for SLEMDD remain lacking. The aim of this study was to identify candidate immunometabolic biomarkers associated with SLEMDD. METHODS: We analysed deep flow cytometry immune phenotyping, gut microbiota profiling, and targeted mass spectrometry-based metabolomics from 99 patients from the LUPIL-2 study (NCT02955615). Biological signatures were identified using unsupervised principal component analysis and supervised decision tree classification. They were then validated in an independent cohort from the TRANSIMMUNOM study (NCT02466217). RESULTS: SLEMDD patients exhibited a distinct immune profile with decreased naïve CD4⁺ T cells and naïve regulatory T cells (Tregs), alongside increased ICOS⁺ effector memory Tregs (94% classification accuracy). Gut microbiota diversity was reduced with depletion of Akkermansia muciniphila and enrichment of Faecalibacterium prausnitzii. Metabolomic analyses revealed disruptions in kynurenine and short-chain fatty acid pathways, including decreased butyrate levels. Integrative analyses demonstrated coordinated alterations linking Treg activation, microbial metabolites, and immune pathways, distinguishing SLEMDD from SLEnon-MDD with up to 85% accuracy. CONCLUSIONS: SLEMDD is associated with an immunometabolic signature involving alterations in Treg phenotype, gut microbiota composition, and metabolic pathways. These findings provide a rationale for future immunoregulatory or microbiota-targeted therapeutic strategies in SLEMDD.
引用
- Ellul P, Tchitchek N, Kvedaraviciute G, et al. An immunometabolic signature of major depressive disorder in systemic lupus erythematosus. Ann Rheum Dis. 2026. PMID: 41862407. doi:10.1016/j.ard.2026.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。